Safe Surgery Guidance for Childhood Melanoma Using Genetics
Part of Cancer, Skin clinical trials.
This study helps doctors decide the safest surgical approach for melanoma and similar skin tumors in children and young adults by using pathology reports and genetic information. The goal is to avoid unnecessary surgery while ensuring the best outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 25 years old or younger
- You have a newly diagnosed melanoma or similar atypical skin tumor (not yet treated with chemotherapy, immunotherapy, radiation, or surgery beyond the initial biopsy)
- Your tumor is only in the skin—no signs of spread to lymph nodes or other body parts on physical exam
- You are in good enough health to participate (your doctor will assess this)
- You have not had re-excision surgery or sentinel lymph node biopsy for this specific tumor yet
- You do not have certain genetic conditions or prior genetic variants linked to melanoma risk
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different ways to manage newly diagnosed melanoma in older adults. It looks at how well surgery plus lymph node biopsy works and how it affects quality of life.
This study looks at people and families with a high risk of melanoma, especially if it runs in the family or is linked to certain genetic conditions. The goal is to better understand what causes melanoma and how to detect it earlier.
This study looks at the DNA and other biology from skin lesions (like melanoma or unusual pigmented moles) in children and teens. It aims to better understand what these tumors are and how they behave, using tissue samples collected during routine care.
This study aims to find better ways to treat melanoma in children, teenagers, and young adults. It may help improve care for patients under 30 years old with certain types of skin growths.
This study tests whether patients with moderate-thickness skin melanoma need additional surgery after their initial tumor removal, or if careful monitoring alone is enough. The goal is to avoid unnecessary surgery while keeping patients safe.
This trial compares two surgeries for invasive melanoma: a narrow removal versus a wider one. It aims to see if a smaller surgery works as well, which could mean less scarring and recovery time.
Hear when a new Clinical Stage I Cutaneous Melanoma AJCC v8 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.